Inhaled Nitric Oxide in Preterm Infants Undergoing Mechanical Ventilation

2006486 citationsJournal Article

Authors

Roberta A. Ballard · Children's Hospital of Philadelphia

William E. Truog · University of Missouri–Kansas City

Avital Cnaan · Children's Hospital of Philadelphia

Richard J. Martin · Case Western Reserve University

Philip L. Ballard · Children's Hospital of Philadelphia

Jeffrey D. Merrill · University of Pennsylvania

Michele C. Walsh

Abstract

Inhaled nitric oxide therapy improves the pulmonary outcome for premature infants who are at risk for bronchopulmonary dysplasia when it is started between 7 and 21 days of age and has no apparent short-term adverse effects. (ClinicalTrials.gov number, NCT00000548 [ClinicalTrials.gov] .).

Topics & Keywords

Neonatal Respiratory Health Research Neuroscience of respiration and sleep Congenital Diaphragmatic Hernia Studies

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 355, Issue 4, pp. 343-353

DOI: 10.1056/nejmoa061088

Field-Weighted Citation Impact: 31.91